Shire’s asset acquisition to boost Regenerative Medicine Division
Shire (NASDAQ:SHPGY) has acquired the assets of a therapeutics firm, including a vascular surgery technology undergoing phase 2 clinical trials in a move that stands to bolster its regenerative medicine division. As part of the agreement, Shire will provide Pervasis with an up-front payment, along with milestone payments tied to the drugs meeting clinical development, […]